In her career at SSHA, Martha has had supervisory and writing responsibility for a wide range of products in categories including oncology, CNS, cardiovascular, endocrine, gastrointestinal, inflammatory disease, and infectious disease. Martha has supervised creative for Eloxatin, Betaseron, Crestor, Coreg, Seroquel, Enbrel, Fragmin, Merrem, TwinRx, Nexium, Prilosec, and B-D Glucose Monitoring Systems. Martha was responsible for the launch of the oral contraceptives Levlen and Tri-Levlen, She also supervised the successful global launch of Detrol/Detrusitol.
Martha's experience also includes writing and supervision for the Premarin family of products, including the launch of Prempro. She was also deeply involved in the first awareness campaigns, both to the consumer and professional of the pervasive problem of osteoporosis.
Martha holds a BS degree from Ithaca College.
The CLIO Awards are the Oscars of advertising and now that healthcare advertising has its own CLIO, I feel our work will get the mainstream recognition it has long deserved. It's great to be part of it!